Alzheimer’s disease can be treated by targeting amyloid-β plaques and diagnosed in vivo by biomarkers, prompting the revision of criteria for the diagnosis and staging of this disease.

中文翻译：

---

阿尔茨海默病诊断和分期的修订标准


阿尔茨海默病可以通过靶向β-淀粉样蛋白斑块进行治疗，并通过生物标志物在体内进行诊断，从而促使对该疾病的诊断和分期标准进行修订。